Sustainable Efforts Urged to Guarantee Supply and Access

Stopping the medication would cause the uncontrollable replication of the virus in the body and potentially make it transmissible.

KOMPAS/DEONISIA ARLINTA

Antiretroviral drug combination type TLE or tenofovir, lamivudine, and efavirenz. The Ministry of Health claims that the availability of this drug is safe until the end of 2019.

JAKARTA, KOMPAS – With the government aiming to eliminate the HIV (human immunodeficiency virus) epidemic in the country by 2030, breakthroughs and strategic solutions are needed to ensure the availability of, and facilitate access to, antiretroviral (ARV) drugs.

In the last few days, this issue has become a concern of many circles, including parties that are active in the country’s HIV control programs.